CCM
BIO icon

Cinctive Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cinctive Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,388
Closed -$996K – 401
2022
Q3 		$996K Sell
2,388
-1,892
-44% -$943K 0.05% 343
2022
Q2 		$2.12M Sell
4,280
-27,370
-86% -$14.3M 0.1% 307
2022
Q1 		$17.8M Buy
+31,650
New +$19.1M 0.81% 25
2021
Q1 		– Sell
-6,150
Closed -$3.58M – 412
2020
Q4 		$3.58M Sell
6,150
-13,191
-68% -$7.51M 0.3% 146
2020
Q3 		$9.97M Buy
19,341
+4,929
+34% +$2.5M 0.91% 16
2020
Q2 		$6.51M Buy
14,412
+2,276
+19% +$1M 0.78% 23
2020
Q1 		$4.25M Sell
12,136
-5,364
-31% -$1.97M 0.99% 27
2019
Q4 		$6.48M Buy
+17,500
New +$6.17M 0.7% 44

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return